المؤلفون: Chatterjee A; McGill University Health Centre, Montreal, Quebec, Canada. Electronic address: avishek.chatterjee@mail.mcgill.ca., Serban M; McGill University Health Centre, Montreal, Quebec, Canada., Abdulkarim B; McGill University Health Centre, Montreal, Quebec, Canada., Panet-Raymond V; McGill University Health Centre, Montreal, Quebec, Canada., Souhami L; McGill University Health Centre, Montreal, Quebec, Canada., Shenouda G; McGill University Health Centre, Montreal, Quebec, Canada., Sabri S; McGill University Health Centre, Montreal, Quebec, Canada., Jean-Claude B; McGill University Health Centre, Montreal, Quebec, Canada., Seuntjens J; McGill University Health Centre, Montreal, Quebec, Canada.

المصدر: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2017 Nov 15; Vol. 99 (4), pp. 1021-1028. Date of Electronic Publication: 2017 Jul 14.

نوع المنشور: Journal Article; Validation Study

بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE

مواضيع طبية MeSH: Astrocytoma/*radiotherapy , Brain Neoplasms/*diagnostic imaging , Brain Neoplasms/*radiotherapy , Glioblastoma/*diagnostic imaging , Glioblastoma/*radiotherapy , Organs at Risk/*diagnostic imaging , Radiotherapy Planning, Computer-Assisted/*methods , Radiotherapy, Intensity-Modulated/*methods, Astrocytoma/diagnostic imaging ; Dose Fractionation, Radiation ; Humans ; Meningeal Neoplasms/diagnostic imaging ; Meningeal Neoplasms/radiotherapy ; Meningioma/diagnostic imaging ; Meningioma/radiotherapy ; Oligodendroglioma/diagnostic imaging ; Oligodendroglioma/radiotherapy ; Radiation Injuries/prevention & control ; Time Factors

المؤلفون: Azoulay M; Department of Oncology, Division of Radiation Oncology, Cedars Cancer Centre, McGill University Health Centre, 1001 Decarie Boulevard, Montréal, QC, H4A 3J1, Canada., Santos F; Department of Oncology, Division of Cancer Epidemiology, McGill University, 546 Pine Avenue West, Montréal, QC, H2W 1S6, Canada., Shenouda G; Department of Oncology, Division of Radiation Oncology, Cedars Cancer Centre, McGill University Health Centre, 1001 Decarie Boulevard, Montréal, QC, H4A 3J1, Canada., Petrecca K; Department of Neurology and Neurosurgery, Montreal Neurological Hospital, McGill University, 3801 University Avenue, Montréal, QC, H3A 2B4, Canada., Oweida A; Research Institute of the McGill University Health Center, Montreal General Hospital, 1625 Pine Avenue West, Montréal, QC, H3G 1A4, Canada., Guiot MC; Department of Pathology, Montreal Neurological Hospital, McGill University, 3801 University Avenue, Montréal, QC, H3A 2B4, Canada., Owen S; Department of Oncology, Division of Medical Oncology, Cedars Cancer Centre, McGill University Health Centre, 1001 Decarie Boulevard, Montréal, QC, H4A 3J1, Canada., Panet-Raymond V; Department of Oncology, Division of Radiation Oncology, Cedars Cancer Centre, McGill University Health Centre, 1001 Decarie Boulevard, Montréal, QC, H4A 3J1, Canada., Souhami L; Department of Oncology, Division of Radiation Oncology, Cedars Cancer Centre, McGill University Health Centre, 1001 Decarie Boulevard, Montréal, QC, H4A 3J1, Canada., Abdulkarim BS; Department of Oncology, Division of Radiation Oncology, Cedars Cancer Centre, McGill University Health Centre, 1001 Decarie Boulevard, Montréal, QC, H4A 3J1, Canada. bassam.abdulkarim@mcgill.ca.

المصدر: Journal of neuro-oncology [J Neurooncol] 2017 May; Vol. 132 (3), pp. 419-426. Date of Electronic Publication: 2017 Apr 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE

مواضيع طبية MeSH: Brain Neoplasms/*therapy , Glioblastoma/*therapy , Neoplasm Recurrence, Local/*therapy , Salvage Therapy/*methods, Adult ; Aged ; Brain Neoplasms/mortality ; Chemotherapy, Adjuvant ; Combined Modality Therapy ; Disease Progression ; Female ; Glioblastoma/mortality ; Glioblastoma/pathology ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neurosurgical Procedures ; Proportional Hazards Models ; Re-Irradiation ; Reoperation ; Retrospective Studies ; Treatment Outcome

المؤلفون: Shenouda G; Department of Radiation Oncology, McGill University Health Centre, Montréal, Québec, Canada. Electronic address: george.shenouda@muhc.mcgill.ca., Souhami L; Department of Radiation Oncology, McGill University Health Centre, Montréal, Québec, Canada., Petrecca K; Department of Neurosurgery, Montreal Neurological Institute, Montréal, Québec, Canada., Owen S; Department of Medical Oncology, McGill University Health Centre, Montréal, Québec, Canada., Panet-Raymond V; Department of Radiation Oncology, McGill University Health Centre, Montréal, Québec, Canada., Guiot MC; Department of Pathology, Montreal Neurological Institute, Montréal, Québec, Canada., Corredor AG; Core Molecular Diagnostic Laboratory, McGill University, Montréal, Québec, Canada., Abdulkarim B; Department of Radiation Oncology, McGill University Health Centre, Montréal, Québec, Canada.

المصدر: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2017 Mar 01; Vol. 97 (3), pp. 487-494. Date of Electronic Publication: 2016 Nov 15.

نوع المنشور: Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Alkylating/*therapeutic use , Brain Neoplasms/*therapy , Chemoradiotherapy/*methods , Dacarbazine/*analogs & derivatives , Glioblastoma/*therapy, Adult ; Brain Neoplasms/genetics ; Chemoradiotherapy/adverse effects ; Chemotherapy, Adjuvant/adverse effects ; Chemotherapy, Adjuvant/methods ; DNA Methylation ; DNA Modification Methylases/genetics ; DNA Repair Enzymes/genetics ; Dacarbazine/therapeutic use ; Disease-Free Survival ; Drug Administration Schedule ; Female ; Follow-Up Studies ; Glioblastoma/genetics ; Humans ; Karnofsky Performance Status ; Male ; Middle Aged ; Neoadjuvant Therapy/methods ; Pancytopenia/etiology ; Prospective Studies ; Radiation Dose Hypofractionation ; Reoperation ; Temozolomide ; Time Factors ; Treatment Failure ; Treatment Outcome ; Tumor Suppressor Proteins/genetics

المؤلفون: Azoulay M; Department of Oncology, Division of Radiation Oncology, McGill University, Montreal General Hospital, 1650 Avenue Cedar, H3G 1A4, Montréal, QC, Canada. melissa.azoulay@mail.mcgill.ca., Santos F; Department of Oncology, Division of Cancer Epidemiology, McGill University, 546 Pine Avenue West, H2W1S6, Montreal, QC, Canada. fabiano.santos@mcgill.ca., Souhami L; Department of Oncology, Division of Radiation Oncology, McGill University, Montreal General Hospital, 1650 Avenue Cedar, H3G 1A4, Montréal, QC, Canada. luis.souhami@mcgill.ca., Panet-Raymond V; Department of Oncology, Division of Radiation Oncology, McGill University, Montreal General Hospital, 1650 Avenue Cedar, H3G 1A4, Montréal, QC, Canada. valerie.panet-raymond@mcgill.ca., Petrecca K; Department of Neurology and Neurosurgery, Montreal Neurological Hospital, McGill University, 3801 University Avenue, H2W1S6, Montreal, QC, Canada. kevin.petrecca@mcgill.ca., Owen S; Division of Medical oncology, Department of Oncology, Montreal General Hospital, McGill University, 1650 Avenue Cedar, H3G 1A4, Montréal, QC, Canada. scott.owen@mcgill.ca., Guiot MC; Department of Pathology, Montreal Neurological Hospital, McGill University, 3801 University Avenue, H3A 2B4, Montreal, QC, Canada. marie.christine.guiot@mcgill.ca., Patyka M; Research Institute of the McGill University Health Center, Montreal General Hospital, 1625 Pine Avenue West, H3G 1A4, Montreal, QC, Canada. mariia.patyka@mail.mcgill.ca., Sabri S; Department of Oncology, Division of Radiation Oncology, McGill University, Montreal General Hospital, 1650 Avenue Cedar, H3G 1A4, Montréal, QC, Canada. siham.sabri@mcgill.ca.; Research Institute of the McGill University Health Center, Montreal General Hospital, 1625 Pine Avenue West, H3G 1A4, Montreal, QC, Canada. siham.sabri@mcgill.ca., Shenouda G; Department of Oncology, Division of Radiation Oncology, McGill University, Montreal General Hospital, 1650 Avenue Cedar, H3G 1A4, Montréal, QC, Canada. george.shenouda@mcgill.ca., Abdulkarim B; Department of Oncology, Division of Radiation Oncology, McGill University, Montreal General Hospital, 1650 Avenue Cedar, H3G 1A4, Montréal, QC, Canada. bassam.abdulkarim@mcgill.ca.

المصدر: Radiation oncology (London, England) [Radiat Oncol] 2015 Apr 26; Vol. 10, pp. 106. Date of Electronic Publication: 2015 Apr 26.

نوع المنشور: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101265111 Publication Model: Electronic Cited Medium: Internet ISSN: 1748-717X (Electronic) Linking ISSN: 1748717X NLM ISO Abbreviation: Radiat Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Dose Fractionation, Radiation*, Brachytherapy/*mortality , Brain Neoplasms/*radiotherapy , Chemoradiotherapy/*mortality , Glioblastoma/*radiotherapy , Radiotherapy, Intensity-Modulated/*methods, Aged ; Antineoplastic Agents, Alkylating/therapeutic use ; Brain Neoplasms/drug therapy ; Brain Neoplasms/mortality ; Brain Neoplasms/pathology ; Dacarbazine/analogs & derivatives ; Dacarbazine/therapeutic use ; Female ; Glioblastoma/drug therapy ; Glioblastoma/mortality ; Glioblastoma/pathology ; Humans ; Male ; Neoplasm Staging ; Prognosis ; Radiotherapy Planning, Computer-Assisted ; Survival Rate ; Temozolomide

المؤلفون: Panet-Raymond V; Department of Oncology, Division of Radiation Oncology, McGill University, Montréal, QC, Canada., Souhami L, Roberge D, Kavan P, Shakibnia L, Muanza T, Lambert C, Leblanc R, Del Maestro R, Guiot MC, Shenouda G

المصدر: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2009 Feb 01; Vol. 73 (2), pp. 473-8. Date of Electronic Publication: 2008 Jun 12.

نوع المنشور: Evaluation Study; Journal Article

بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE

مواضيع طبية MeSH: Brain Neoplasms*/drug therapy , Brain Neoplasms*/mortality , Brain Neoplasms*/pathology , Brain Neoplasms*/radiotherapy , Glioblastoma*/drug therapy , Glioblastoma*/mortality , Glioblastoma*/pathology , Glioblastoma*/radiotherapy, Antineoplastic Agents, Alkylating/*therapeutic use , Dacarbazine/*analogs & derivatives , Radiotherapy, Intensity-Modulated/*methods, Adult ; Aged ; Analysis of Variance ; Antineoplastic Agents, Alkylating/adverse effects ; Chemotherapy, Adjuvant/adverse effects ; Dacarbazine/adverse effects ; Dacarbazine/therapeutic use ; Disease-Free Survival ; Dose Fractionation, Radiation ; Drug Administration Schedule ; Female ; Humans ; Male ; Methylation ; Middle Aged ; O(6)-Methylguanine-DNA Methyltransferase/metabolism ; Retrospective Studies ; Temozolomide ; Treatment Outcome ; Tumor Burden

المؤلفون: Sultanem K; Department of Oncology, Division of Radiation Oncology, McGill University, Montréal, Quebec, Canada. ksultane@roc.jgh.mcgill.ca, Patrocinio H, Lambert C, Corns R, Leblanc R, Parker W, Shenouda G, Souhami L

المصدر: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2004 Jan 01; Vol. 58 (1), pp. 247-52.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print Cited Medium: Print ISSN: 0360-3016 (Print) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE

مواضيع طبية MeSH: Brain Neoplasms/*radiotherapy , Glioblastoma/*radiotherapy , Radiotherapy, Conformal/*methods, Adult ; Age Factors ; Aged ; Dose Fractionation, Radiation ; Female ; Humans ; Karnofsky Performance Status ; Male ; Middle Aged ; Prognosis ; Prospective Studies ; Radiotherapy, Conformal/adverse effects

المؤلفون: Muanza T; Department of Oncology, McGill University, Montreal, Quebec, Canada., Shenouda G, Souhami L, Leblanc R, Mohr G, Corns R, Langleben A

المصدر: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques [Can J Neurol Sci] 2000 Nov; Vol. 27 (4), pp. 302-6.

نوع المنشور: Clinical Trial; Clinical Trial, Phase I; Journal Article

بيانات الدورية: Publisher: published by Cambridge University Press for the Canadian Neurological Sciences Federation Country of Publication: England NLM ID: 0415227 Publication Model: Print Cited Medium: Print ISSN: 0317-1671 (Print) Linking ISSN: 03171671 NLM ISO Abbreviation: Can J Neurol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Hormonal/*therapeutic use , Brain Neoplasms/*drug therapy , Glioblastoma/*drug therapy , Tamoxifen/*therapeutic use, Adult ; Aged ; Brain Neoplasms/radiotherapy ; Female ; Follow-Up Studies ; Glioblastoma/radiotherapy ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Survival Analysis

المؤلفون: Preul MC; Department of Neurosurgery, McGill University, Montreal, Quebec, Canada., Caramanos Z, Villemure JG, Shenouda G, LeBlanc R, Langleben A, Arnold DL

المصدر: Neurosurgery [Neurosurgery] 2000 Feb; Vol. 46 (2), pp. 306-18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins, Inc Country of Publication: United States NLM ID: 7802914 Publication Model: Print Cited Medium: Print ISSN: 0148-396X (Print) Linking ISSN: 0148396X NLM ISO Abbreviation: Neurosurgery Subsets: MEDLINE

مواضيع طبية MeSH: Magnetic Resonance Spectroscopy*, Antineoplastic Agents, Hormonal/*therapeutic use , Astrocytoma/*drug therapy , Brain Neoplasms/*drug therapy , Glioblastoma/*drug therapy , Neoplasm Recurrence, Local/*drug therapy , Tamoxifen/*therapeutic use, Administration, Oral ; Adolescent ; Adult ; Aged ; Aspartic Acid/analogs & derivatives ; Aspartic Acid/metabolism ; Astrocytoma/diagnosis ; Astrocytoma/metabolism ; Brain Neoplasms/diagnosis ; Brain Neoplasms/metabolism ; Choline/metabolism ; Creatine/metabolism ; Dose-Response Relationship, Drug ; Female ; Glioblastoma/diagnosis ; Glioblastoma/metabolism ; Humans ; Lipid Metabolism ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neoplasm Recurrence, Local/diagnosis ; Neoplasm Recurrence, Local/metabolism ; Phosphocreatine/metabolism ; Treatment Outcome ; Tumor Stem Cell Assay

المؤلفون: Shenouda G; Department of Radiation Oncology, McGill University, Montreal, Canada., Souhami L, Podgorsak EB, Bahary JP, Villemure JG, Caron JL, Mohr G

المصدر: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques [Can J Neurol Sci] 1997 May; Vol. 24 (2), pp. 110-5.

نوع المنشور: Clinical Trial; Journal Article

بيانات الدورية: Publisher: published by Cambridge University Press for the Canadian Neurological Sciences Federation Country of Publication: England NLM ID: 0415227 Publication Model: Print Cited Medium: Print ISSN: 0317-1671 (Print) Linking ISSN: 03171671 NLM ISO Abbreviation: Can J Neurol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Radiosurgery*/adverse effects, Brain Neoplasms/*therapy , Glioblastoma/*therapy, Adult ; Aged ; Brain Neoplasms/radiotherapy ; Brain Neoplasms/surgery ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Glioblastoma/radiotherapy ; Glioblastoma/surgery ; Humans ; Male ; Middle Aged ; Prognosis ; Quality of Life ; Radiation Dosage ; Recurrence ; Survival Analysis ; Treatment Outcome

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.